GlassScriptPhysician profile
Richard Bryson
NPI 1417272261
$8,402.97
in general payments reported to CMS, 2019-2025
49 companies · $224 in 2025
The $224 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,391 · 2020: $1,328 · 2021: $1,604 · 2022: $1,834 · 2023: $1,487 · 2024: $535 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,138 · Education: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,137.97 |
| Education | $107.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $881.81 | 2019-2023 | Myrbetriq, Xtandi |
| Intuitive Surgical, INC. | $850.04 | 2019-2020 | |
| Janssen Biotech, INC. | $754.43 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Pfizer INC. | $655.32 | 2019-2024 | |
| Sumitomo Pharma America, INC. | $453.34 | 2023-2024 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $436.01 | 2019-2024 | Edex, Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $413.49 | 2021-2024 | |
| Boston Scientific Corporation | $305.49 | 2019-2023 | Ams 700, Greenlight Xps |
| Allergan, INC. | $297.05 | 2019-2021 | |
| Urovant Sciences INC | $287.88 | 2021-2022 | |
| Abbvie INC. | $283.04 | 2020-2024 | Botox |
| United Medical Systems (De), INC. | $276.61 | 2022 | |
| Dendreon Pharmaceuticals LLC | $264.84 | 2019-2021 | |
| Antares Pharma, INC. | $200.70 | 2021-2023 | Nocdurna, Xyosted, Tlando |
| 180 Medical, INC. | $197.81 | 2019-2024 | Lofric Origo |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bryson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.